AMGN vs GSK: 2026 Comparison
Verdict for Passive Income: It's a Draw
Distinct Roles: GSK is a stable core holding, while AMGN is a high-growth, high-volatility play.
Distinct Roles: GSK is a stable core holding, while AMGN is a high-growth, high-volatility play.
While both are excellent, AMGN edges ahead due to slightly better historical returns and lower volatility, making it the ideal core holding.
Dividend Yield
CAGR (15y)
Stress Test: How Did They React?
Real historical performance during key market events (Crashes & Rallies).
| Market Event | AMGN Return | GSK Return | Verdict |
|---|---|---|---|
COVID-19 Crash Global pandemic lockdown selling pressure 2020-02-19 • 2020-03-23 | -16.6% | -25.7% | AMGN Wins |
Post-COVID Recovery QE-fueled tech and growth rally 2020-03-24 • 2021-12-31 | +17.0% | +42.2% | GSK Wins |
2022 Inflation Bear Rate hikes and tech valuations reset 2022-01-01 • 2022-10-12 | +11.4% | -28.1% | AMGN Wins |
AI Boom & Rally Generative AI hype driving Mega Caps 2023-01-01 • Present | +37.7% | +55.4% | GSK Wins |
👤 Which one is right for you?
Select your primary investment goal to see the recommended choice:
In terms of dividend income, AMGN and GSK are effectively identical.
Growth of $10,000
Historical performance if you invested $10k at the start
Head-to-Head Metrics
Direct comparison of key investment characteristics
| Metric | AMGN | GSK | Contextual Difference |
|---|---|---|---|
| Beta (Volatility) | 24.51% | 20.63% | GSK is less volatile |
Beta (Volatility)
Aswin oversees all content quality and data validation at TradingKite. With a background in engineering and a passion for financial transparency, he ensures every insight meets our rigorous editorial standards.
Data sourced via verified partners and processed through TradingKite's proprietary validation engine.